Senate Democrats have an ironic sense of timing. Mere days after a report raised the long-term costs of the Medicare Part D prescription drug benefit by $5 trillion, due in part to Democrats’ Inflation Reduction Act, Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and his colleagues released a white paper that would double down on the IRA’s failed policies. It’s the latest illustration of how the party’s “affordability” agenda is anything but for taxpayers.
Major Changes to Part D
